Boston Scientific Sees $100 Mil. Potential In BEI Medical’s ThermAblator
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will expand its women's health promotional reach to include gynecologists, in hopes of developing the menorrhagia market following the $95 mil. acquisition of BEI Medical's ablation technology
You may also be interested in...
Cytyc Prepares To Launch ThinPrep Imager; Women’s Health Recap For 2002
Cytyc's ThinPrep and TriPath's SurePath liquid-based cytology Pap tests could receive a boost in 2003 from a positive NICE technology assessment review
Cytyc Prepares To Launch ThinPrep Imager; Women’s Health Recap For 2002
Cytyc's ThinPrep and TriPath's SurePath liquid-based cytology Pap tests could receive a boost in 2003 from a positive NICE technology assessment review
AMS’ CryoGen Purchase Anticipates Expanded HerOption Applications
American Medical Systems will seek to extend HerOption endometrial ablation technology for fibroid treatment following the firm's acquisition of CryoGen